Should the treatment of osteoporosis be more selective?

Osteoporosis International

Volumn 14, Issue 2, 2003, Pages 99-102

  Nordin, B E Christopher ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TIBOLONE; VITAMIN D;

BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; FRACTURE REDUCTION; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKELETON;

BONE RESORPTION; CLINICAL TRIALS; HUMANS; OSTEOPOROSIS; PRACTICE GUIDELINES;

EID: 1842668832     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1366-z     Document Type: Review

References (30)

1. Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541
2. Reginster J-Y, Minne HW, Sorensen OH et al. (2000) Randomized trial of the effects of risedronate on vertebtral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83-91
3. Riis BJ, Ise J, Stein T von, Bagger Y, Christiansen C (2001) Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis. J Bone Miner Res 16:1871-1878
4. Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. J Am Med Assoc 282:637-645
5. Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362
6. Garnero P, Hausherr E, Chapuy M-C et al. (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531-1538
7. Riggs BL, Melton LJ (2002) Editorial. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 17:11-14
8. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878-883
9. Morris HA, Need AG, Horowitz M, O'Loughlin PD, Nordin BEC (1991) Calcium absorption in normal and osteoporotic postmenopausal women. Calcif Tissue Int 49:240-243
10. 47Ca retention to season and rates of bone loss in healthy postmenopausal women. J Bone Miner Res 6:1323-1329
11. Nordin BEC, Polley KJ (1987) Metabolic consequences of the menopause. A cross-sectional, longitudinal, and intervention study on 557 normal postmenopausal women. Calcif Tissue Int 41:S1-S60
12. Nordin BEC, Morris HA, Wishart JM, Scopacasa F, Horowitz M, Need AG, Clifton PM (1998) Modification and validation of a single-isotope radiocalcium absorption test. J Nucl Med 39:108-113
13. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF (1995) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80:406-411
14. Nordin BEC, Need AG, Morris HA, Horowitz M (1999) Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporos Int 9:351-357
15. Nordin BEC, Need AG, Morris HA, Horowitz M (1993) The nature and significance of the relation between urine sodium and urine calcium in women. J Nutr 123:1615-1622
16. Delmas PD (2000) Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Osteoporos Int (Suppl 6):S66-S76
17. Bjarnason NH, Christiansen C (2000) Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 26:561-569
18. Scopacasa F, Horowitz M, Wishart J, Need AG, Morris HA, Wittert G, Nordin BEC (1998) Calcium supplementation suppresses bone resorption in early postmenopausal women. Calcif Tissue Int 62:8-12
19. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R (1994) The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 79:730-735
20. Need AG, Horowitz M, Philcox JC, Nordin BEC (1987) Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium. Min Electrolyte Metab 13:112-116
21. Nordin BEC (1997) Calcium and osteoporosis. Nutrition 13:664-686
22. Need AG, Morris HA, Horowitz M, Nordin BEC (1997) The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status. Calcif Tissue Int 61:6-9
23. Need AG, Morris HA, Cleghorn DB, DeNichilo D, Horowitz M, Nordin BEC (1991) Effects of salt restriction on urine hydroxyproline excretion in postmenopausal women. Arch Intern Med 151:757-759
24. Selby PL, Peacock M, Barkworth SA, Brown WB, Taylor GA (1985) Early effects of ethinyloestradiol and norethisterone treatment in postmenopausal women on bone resorption and calcium regulating hormones. Clin Sci 69:265-271
25. Neer RM, Arnaud CD, Zanchetta JR et al. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
26. Mundly GR (2001) Statins and their potential for osteoporosis. Bone 29:495-497
27. Nordin BEC, Need AG, Horowitz M, Morris HA (1996) Understanding and managing osteoporosis in the elderly. Clin Geriatrics 4:73-88
28. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268-1274
29. Bjarnason NH, Bjarnason K, Hassager C, Christiansen C (1997) The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women. Bone 20:151-155
30. Cummings SR, Black DM, Thompson DE et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. J Am Med Assoc 280:2077-2082